An interventional study of Behavioral Economics (BE) recruitment strategies and Biofeedback-based virtual reality (VR-BF) in Surgery and Adolescent Behavior, sponsored by Vanessa Olbrecht. Terminated at 1 site in United States. Open to participants aged 12 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-20.
Sponsored by Vanessa Olbrecht · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 165 studies in Adolescent Behavior with a site in United States — 20 open to participants now, 30 under way, none of them phase 3. Adolescent Behavior · United States.
Among the 165 studies in Adolescent Behavior with a site in United States, this one is the 88th largest by enrollment of the 150 interventional ones that give a count, is one of 23 that started in 2022, is one of 140 with no phase, and was the 122nd registered.
306 studies on the registry are indexed under Adolescent Behavior; 48 are open to participants now.
Browse Adolescent Behavior studies →20 of the 165 studies in Adolescent Behavior with a site in United States are open now. Recruiting first, the newest first:
University of North Carolina, Chapel Hill · Sites in United States
Ages 18+
Columbia University · Sites in United States, Puerto Rico
Ages 11–14 · Healthy volunteers
Massachusetts General Hospital · Sites in United States
Ages 12–18
Child Trends · Sites in United States
Ages 15–24 · Women only
Boston University Charles River Campus · Sites in United States
Ages 14+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 30 Adolescent Behavior studies recruiting now, 8 (27%) set no upper age limit and 22 (73%) stop at 75 or younger; 29 take children under 18; 16 take healthy volunteers.
This study: 12 Years to 18 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
165 studies; the count open now beside each. This study's row is marked.
First in 1999; this study’s year is marked. 23 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 128 is below the median of 174 across 257 interventional studies indexed under Adolescent Behavior.
Median enrollment 171 across the 150 interventional studies, 103 across the 14 observational. Of the 127 that completed or were terminated, 37 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 165 have an industry lead sponsor. The 10 most frequent:
Vanessa Olbrecht is the lead sponsor of 2 studies on the registry; none are open to participants now.
Vanessa Olbrecht has 1 study filed under Adolescent Behavior — fewer than ten, so there is no comparison to draw.
10 of the studies in Adolescent Behavior with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06019377Portland State UniversityIntervention to Enhance Coping and Help-seeking Among Youth in Foster Care | 2026-12-31 |
| NCT05169385Brown UniversityParent SMART (Substance Misuse in Adolescents in Residential Treatment) | 2027-02-02 |
| NCT06176300Virginia Commonwealth UniversityEvaluation of Violence Prevention Strategies to Prevent and Reduce Community Levels of Youth Violence | 2027-02-28 |
| NCT07303062University of North Carolina, Chapel HillAdolescent Mental Health Parenting Program for Child-Adult Relationship Enhancement | 2027-03-01 |
| NCT05748730University of PittsburghClinical Trial for Integrated Care to Help At Risk Teens (iCHART) Intervention | 2027-04-30 |
Add all 10 to your calendar (.ics) → With an account.
Among the 165 studies in Adolescent Behavior with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To determine the impact of the application of behavioral economic strategies on recruitment of pediatric patients into a randomized clinical trial assessing the impact of technology-based interventions on postoperative pain management.
Patients will be asked to watch one of two videos in either Phase 1 or Phase 2 relating to recruitment and fill out a survey to determine their likelihood to enroll in a research study. Patients 12-18 years of age presenting for surgery that requires postoperative admission and usually requires narcotic administration.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
We are applying Behavioral Economics (BE)-based messaging and presentation strategies to patient recruitment and determining whether these strategies may enhance patient recruitment into a pediatric randomized clinical trial. Phase 1 will focus on patients that would be enrolled into a biofeedback-based virtual reality (VR-BF) arm.
Behavioral: Behavioral Economics (BE) recruitment strategies · Other: Biofeedback-based virtual reality (VR-BF)
A similar to BE-based recruitment video using a standard biological approach on teenagers' decision to enroll in a clinical study will be used as comparison. Phase 1 will focus on patients that would be enrolled into a biofeedback-based virtual reality (VR-BF) arm.
Other: Biofeedback-based virtual reality (VR-BF)
We are applying Behavioral Economics (BE)-based messaging and presentation strategies to patient recruitment and determining whether these strategies may enhance patient recruitment into a pediatric randomized clinical trial. Phase 2 will focus on patients that would be enrolled into the control arm of a clinical trial with a control intervention, Manage My Pain application.
Behavioral: Behavioral Economics (BE) recruitment strategies · Other: Manage My Pain
A similar to BE-based recruitment video using a standard biological approach on teenagers' decision to enroll in a clinical study will be used as comparison. Phase 2 will focus on patients that would be enrolled into the control arm of a clinical trial with a control intervention, Manage My Pain application.
Other: Manage My Pain
Behavioral economics (BE), a method of economic analysis that applies psychological insights into human behavior to explain economic decision-making, has broad applicability and its techniques offer a novel way that may be applied to try to help enhance study recruitment and enrollment.
Phase 1 will focus on patients that would be enrolled into a biofeedback-based virtual reality (VR-BF) arm.
Commercially available and free app to track, analyze and monitor pain.
To Determine the Impact of the Application of Behavioral Economic Strategies on Recruitment of Pediatric Patients Into a Randomized Clinical Trial Assessing the Impact of Technology-based Interventions on Postoperative Pain Management.
Survey to identify likelihood to participate in study using a 5-point Likert scale (1="Extremely Unlikely" to 5="Extremely Likely").
Time frame: Baseline
Willingness to Participate in Clinical Trial
If given the opportunity, would you participate in the clinical trial?
Time frame: Baseline
Intention to Adhere to Therapy - Would Practice
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would practice this technology at least once per day before surgery.
Time frame: Baseline
Acceptability of Therapy - Excitement
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would be excited to use this technology.
Time frame: Baseline
Perception of Efficacy - Less Pain
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe this technology would help me have less pain after surgery.
Time frame: Baseline
Perception of Risk - Side Effects
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am worried that this technology would have a lot of side effects.
Time frame: Baseline
Opinion of Treatment Burden - Ease of Use
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I feel that this technology would be easy to use.
Time frame: Baseline
Intention to Adhere to Therapy - Would Use
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would use this technology at least once per day after surgery while I was still needing it.
Time frame: Baseline
Acceptability of Therapy - Pain Medication
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would like to use this technology to help me take less pain medication.
Time frame: Baseline
Acceptability of Therapy - Recommend to Others
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would recommend this therapy to other individuals undergoing surgery.
Time frame: Baseline
Acceptability of Therapy - Preference
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would prefer using this technology over taking pain medications.
Time frame: Baseline
Perception of Efficacy - Less Pain Medication
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe that this technology would help me use less pain medication after surgery.
Time frame: Baseline
Perception of Risk - Amount
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe that this technology would be too risky for me to use.
Time frame: Baseline
Opinion of Treatment Burden - Independence
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would feel comfortable using this technology independently without supervision.
Time frame: Baseline
Opinion of Treatment Burden - Familiar
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am familiar with how to use this type of technology.
Time frame: Baseline
Opinion of Treatment Burden - Pay for Technology
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would pay for the opportunity to use this technology during my recovery. I am comfortably using technologies like this.
Time frame: Baseline
Opinion of Treatment Burden - Technology Comfort
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am comfortably using technologies like this.
Time frame: Baseline
| Milestone | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological | Phase 2 - Manage My Pain BE | Phase 2 - Manage My Pain Biological |
|---|---|---|---|---|
| Started | 64 | 64 | 0 | 0 |
| Completed | 64 | 64 | 0 | 0 |
| Not completed | 0 | 0 | 0 | 0 |
Survey to identify likelihood to participate in study using a 5-point Likert scale (1="Extremely Unlikely" to 5="Extremely Likely").
| score on a scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Interest in using ForeVR | 4 (3 to 4) | 4 (3 to 4) |
| Interest in participating in clinical trial involving ForeVR | 3 (3 to 4) | 4 (3 to 4) |
If given the opportunity, would you participate in the clinical trial?
| Participants | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Yes | 48 | 49 |
| No | 16 | 13 |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would practice this technology at least once per day before surgery.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Intention to Adhere to Therapy - Would Practice | 4 (3 to 4) | 4 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would be excited to use this technology.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Acceptability of Therapy - Excitement | 4 (3 to 4) | 4 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe this technology would help me have less pain after surgery.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Perception of Efficacy - Less Pain | 3 (3 to 4) | 3 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am worried that this technology would have a lot of side effects.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Perception of Risk - Side Effects | 2 (1 to 2) | 2 (2 to 3) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I feel that this technology would be easy to use.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Opinion of Treatment Burden - Ease of Use | 3 (3 to 4) | 4 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would use this technology at least once per day after surgery while I was still needing it.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Intention to Adhere to Therapy - Would Use | 4 (3 to 4) | 4 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would like to use this technology to help me take less pain medication.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Acceptability of Therapy - Pain Medication | 4 (3 to 4) | 4 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would recommend this therapy to other individuals undergoing surgery.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Acceptability of Therapy - Recommend to Others | 4 (3 to 4) | 4 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would prefer using this technology over taking pain medications.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Acceptability of Therapy - Preference | 4 (3 to 4) | 4 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe that this technology would help me use less pain medication after surgery.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Perception of Efficacy - Less Pain Medication | 3 (3 to 4) | 3 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe that this technology would be too risky for me to use.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Perception of Risk - Amount | 2 (1 to 2) | 2 (2 to 3) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would feel comfortable using this technology independently without supervision.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Opinion of Treatment Burden - Independence | 3 (3 to 4) | 4 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am familiar with how to use this type of technology.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Opinion of Treatment Burden - Familiar | 3 (3 to 4) | 4 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would pay for the opportunity to use this technology during my recovery. I am comfortably using technologies like this.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Opinion of Treatment Burden - Pay for Technology | 3 (3 to 4) | 4 (3 to 4) |
Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am comfortably using technologies like this.
| score on a Likert scale | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological |
|---|---|---|
| Opinion of Treatment Burden - Technology Comfort | 3 (3 to 4) | 4 (3 to 4) |
Collected over 1 day. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Phase 1 - VR-BF BE | 0/64 (0%) | 0/64 (0%) | 0/64 (0%) |
| Phase 1 - VR-BF Biological | 0/64 (0%) | 0/64 (0%) | 0/64 (0%) |
| Age, Continuous(years) | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological | Total |
|---|---|---|---|
| Mean | 14.7 ± 1.6 | 14.6 ± 1.6 | 14.7 ± 1.6 |
| Sex/Gender, Customized(Participants) | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological | Total |
|---|---|---|---|
| Male | 31 | 33 | 64 |
| Female | 32 | 31 | 63 |
| Prefer not to answer | 1 | 0 | 1 |
| Ethnicity (NIH/OMB)(Participants) | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological | Total |
|---|---|---|---|
| Hispanic or Latino | 4 | 3 | 7 |
| Not Hispanic or Latino | 60 | 61 | 121 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological | Total |
|---|---|---|---|
| American Indian or Alaska Native | 1 | 2 | 3 |
| Asian | 5 | 1 | 6 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 8 | 5 | 13 |
| White | 50 | 53 | 103 |
| More than one race | 0 | 2 | 2 |
| Unknown or Not Reported | 0 | 1 | 1 |
| Region of Enrollment(participants) | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological | Total |
|---|---|---|---|
| United States | 64 | 64 | 128 |
| Previous pain management(Participants) | Phase 1 - VR-BF BE | Phase 1 - VR-BF Biological | Total |
|---|---|---|---|
| Over-the-counter pain medication | 59 | 58 | 117 |
| Massage | 7 | 13 | 20 |
| Acupuncture | 1 | 1 | 2 |
| Chiropractor | 6 | 4 | 10 |
| Prescribed pain medication | 13 | 20 | 33 |
| Deep breathing, meditation, guided imagery, relaxation or similar approach | 9 | 16 | 25 |
| Have not had pain in the past | 0 | 0 | 0 |
| Other | 3 | 4 | 7 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from May 2022 to primary completion in Sep 2022, 3 months.
Results were first posted in Dec 2024, 2 years 3 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vanessa Olbrecht